Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

November 1, 1985; Volume 135,Issue 5

COMMUNICATIONS

  • You have accessRestricted access
    Evidence that lymphokine-activated killer cells and natural killer cells are distinct based on an analysis of congenitally immunodeficient mice.
    G L Andriole, J J Mulé, C T Hansen, W M Linehan and S A Rosenberg
    J Immunol November 1, 1985, 135 (5) 2911-2913;

ARTICLES

  • You have accessRestricted access
    Qualitative and quantitative studies of antigen-presenting cell function by using I-A-expressing L cells.
    R I Lechler, M A Norcross and R N Germain
    J Immunol November 1, 1985, 135 (5) 2914-2922;
  • You have accessRestricted access
    Class II histocompatibility antigen-mediated immunologic function of normal articular chondrocytes.
    M L Tiku, S Liu, C W Weaver, M Teodorescu and J L Skosey
    J Immunol November 1, 1985, 135 (5) 2923-2928;
  • You have accessRestricted access
    Correlation between keratinocyte expression of Ia and the intensity and duration of contact hypersensitivity responses in mice.
    L K Roberts, G J Spangrude, R A Daynes and G G Krueger
    J Immunol November 1, 1985, 135 (5) 2929-2936;
  • You have accessRestricted access
    Antigen presentation by splenic B cells: resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell responses.
    J I Krieger, S F Grammer, H M Grey and R W Chesnut
    J Immunol November 1, 1985, 135 (5) 2937-2945;
  • You have accessRestricted access
    Signals involved in T cell activation. I. Phorbol esters enhance responsiveness but cannot replace intact accessory cells in the induction of mitogen-stimulated T cell proliferation.
    L Davis and P E Lipsky
    J Immunol November 1, 1985, 135 (5) 2946-2952;
  • You have accessRestricted access
    Dissection of the functions of antigen-presenting cells in the induction of T cell activation.
    A K Roska and P E Lipsky
    J Immunol November 1, 1985, 135 (5) 2953-2961;
  • You have accessRestricted access
    Active transformation of tolerogenic to immunogenic signals in T and B cells by 8-bromoguanosine.
    W V Scheuer, M G Goodman, D E Parks and W O Weigle
    J Immunol November 1, 1985, 135 (5) 2962-2966;
  • You have accessRestricted access
    Specific neonatally induced tolerance to Mls locus determinants.
    S Macphail, S T Ishizaka, M J Bykowsky, E C Lattime and O Stutman
    J Immunol November 1, 1985, 135 (5) 2967-2974;
  • You have accessRestricted access
    Orally induced tolerance generates an efferently acting suppressor T cell and an acceptor T cell that together down-regulate contact sensitivity.
    S C Gautam and J R Battisto
    J Immunol November 1, 1985, 135 (5) 2975-2983;
  • You have accessRestricted access
    Suppressor T cells, distinct from "veto cells," are induced by alloantigen priming and mediate transferable suppression of cytotoxic T lymphocyte responses in vivo.
    T Owens and I N Crispe
    J Immunol November 1, 1985, 135 (5) 2984-2989;
  • You have accessRestricted access
    Genetics of insulin-specific helper and suppressor T cells in nonresponder mice.
    P E Jensen and J A Kapp
    J Immunol November 1, 1985, 135 (5) 2990-2995;
  • You have accessRestricted access
    Mechanisms of suppressed cell-mediated immunity and impaired antigen-induced interleukin 2 production in granuloma-bearing mice.
    K Kobayashi, C Allred and T Yoshida
    J Immunol November 1, 1985, 135 (5) 2996-3003;
  • You have accessRestricted access
    Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
    R Korngold and J Sprent
    J Immunol November 1, 1985, 135 (5) 3004-3010;
  • You have accessRestricted access
    Temperature sensitivity of interleukin-dependent murine T cell proliferation: Q2 mapping of the responses of peanut agglutinin-negative thymocytes.
    D F Hanson and P A Murphy
    J Immunol November 1, 1985, 135 (5) 3011-3020;
  • You have accessRestricted access
    Two subpopulations of stem cells for T cell lineage.
    Y Katsura, T Amagai, T Kina, T Sado and S Nishikawa
    J Immunol November 1, 1985, 135 (5) 3021-3027;
  • You have accessRestricted access
    Fine specificity of antigen recognition by T cell hybridoma clones specific for poly-18: a synthetic polypeptide antigen of defined sequence and conformation.
    A Fotedar, M Boyer, W Smart, J Widtman, E Fraga and B Singh
    J Immunol November 1, 1985, 135 (5) 3028-3033;
  • You have accessRestricted access
    Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells.
    S De Fazio, W C Hartner, A P Monaco and J J Gozzo
    J Immunol November 1, 1985, 135 (5) 3034-3038;
  • You have accessRestricted access
    Interactions and quantitative analysis of immunoregulatory cells in the chicken thymus.
    R L Boyd, K Hàla and G Wick
    J Immunol November 1, 1985, 135 (5) 3039-3049;
  • You have accessRestricted access
    Differences in antibody repertoires for (4-hydroxy-3-nitrophenyl)acetyl (NP) in splenic vs immature bone marrow precursor cells.
    R L Riley and N R Klinman
    J Immunol November 1, 1985, 135 (5) 3050-3055;
  • You have accessRestricted access
    G0 B cells activated by anti-mu acquire the ability to proliferate in response to B cell-activating factors independently from entry into G1 phase.
    J J Proust, F J Chrest, M A Buchholz and A A Nordin
    J Immunol November 1, 1985, 135 (5) 3056-3061;
  • You have accessRestricted access
    Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using antigen-ricin A chain immunotoxin.
    C A Olsberg, T M Mikiten and K A Krolick
    J Immunol November 1, 1985, 135 (5) 3062-3067;
  • You have accessRestricted access
    Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    G R Nemerow, M E McNaughton and N R Cooper
    J Immunol November 1, 1985, 135 (5) 3068-3073;
  • You have accessRestricted access
    One allogeneic cytolytic T lymphocyte clone distinguishes three different HLA-B27 subtypes: identification of amino acid residues influencing the specificity and avidity of recognition.
    P Aparicio, M A Vega and J A López de Castro
    J Immunol November 1, 1985, 135 (5) 3074-3081;
  • You have accessRestricted access
    HLA regulates postrenal transplant CML nonreactivity.
    E Goulmy, E Blokland, G Persijn, L C Paul, J Wilmink and J J van Rood
    J Immunol November 1, 1985, 135 (5) 3082-3086;
  • You have accessRestricted access
    Characterization of the requirements for human T cell mitogenesis by using suboptimal concentrations of phytohemagglutinin.
    G B Mills, J W Lee, R K Cheung and E W Gelfand
    J Immunol November 1, 1985, 135 (5) 3087-3093;
  • You have accessRestricted access
    Human peripheral blood lymphocytes from recently vaccinated individuals produce both type-specific and intertypic cross-reacting neutralizing antibody on in vitro stimulation with one type of poliovirus.
    F G Uytdehaag, H G Loggen, T Logtenberg, R A Lichtveld, B van Steenis, J A van Asten and A D Osterhaus
    J Immunol November 1, 1985, 135 (5) 3094-3101;
  • You have accessRestricted access
    Heritable lymphocyte function-associated antigen-1 deficiency: abnormalities of cytotoxicity and proliferation associated with abnormal expression of LFA-1.
    A M Krensky, S J Mentzer, C Clayberger, D C Anderson, F C Schmalstieg, S J Burakoff and T A Springer
    J Immunol November 1, 1985, 135 (5) 3102-3108;
  • You have accessRestricted access
    Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL 2.
    R I Fox, A N Theofilopoulos and A Altman
    J Immunol November 1, 1985, 135 (5) 3109-3115;
  • You have accessRestricted access
    Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone.
    J Gohill, P D Cary, M Couppez and M J Fritzler
    J Immunol November 1, 1985, 135 (5) 3116-3121;
  • You have accessRestricted access
    Murine polyspecific antibodies. I. Monoclonal and serum anti-DNA antibodies cross-reactive with 2,4,6-trinitrophenyl derivatives.
    D Serban, C Rordorf-Adam, Y Z Sun and J Gordon
    J Immunol November 1, 1985, 135 (5) 3122-3127;
  • You have accessRestricted access
    Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations.
    H J Schluesener and H Wekerle
    J Immunol November 1, 1985, 135 (5) 3128-3133;
  • You have accessRestricted access
    Immune complexes in purpura hemorrhagica of the horse contain IgA and M antigen of Streptococcus equi.
    J E Galan and J F Timoney
    J Immunol November 1, 1985, 135 (5) 3134-3137;
  • You have accessRestricted access
    Activation, proliferation, and differentiation of circulating B cells in autoimmune thyroid disease.
    A P Weetman, D J Volkman, K D Burman and A S Fauci
    J Immunol November 1, 1985, 135 (5) 3138-3143;
  • You have accessRestricted access
    Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.
    J J van Dongen, H Hooijkaas, M Comans-Bitter, K Hählen, A de Klein, G E van Zanen, M B van't Veer, J Abels and R Benner
    J Immunol November 1, 1985, 135 (5) 3144-3150;
  • You have accessRestricted access
    Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    J S McDougal, A Mawle, S P Cort, J K Nicholson, G D Cross, J A Scheppler-Campbell, D Hicks and J Sligh
    J Immunol November 1, 1985, 135 (5) 3151-3162;
  • You have accessRestricted access
    Elevated allogeneic cytotoxic T lymphocyte activity in peripheral blood leukocytes of homosexual men.
    K S Tung, F Koster, D C Bernstein, P W Kriebel, S M Payne and G M Shearer
    J Immunol November 1, 1985, 135 (5) 3163-3171;
  • You have accessRestricted access
    Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
    L A Rubin, C C Kurman, M E Fritz, W E Biddison, B Boutin, R Yarchoan and D L Nelson
    J Immunol November 1, 1985, 135 (5) 3172-3177;
  • You have accessRestricted access
    Murine leukemic cells inhibit IL 2 production by susceptible syngeneic splenocytes.
    L J Jenski and T Ledford
    J Immunol November 1, 1985, 135 (5) 3178-3183;
  • You have accessRestricted access
    Biological and biochemical characterization of bovine interleukin 2. Studies with cloned bovine T cells.
    W C Brown and D J Grab
    J Immunol November 1, 1985, 135 (5) 3184-3190;
  • You have accessRestricted access
    Regulation of IL 3 expression by glucocorticoids in cloned murine T lymphocytes.
    J A Culpepper and F Lee
    J Immunol November 1, 1985, 135 (5) 3191-3197;
  • You have accessRestricted access
    Differential interleukin 1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes: relationship to cell maturity.
    J A Elias, A D Schreiber, K Gustilo, P Chien, M D Rossman, P J Lammie and R P Daniele
    J Immunol November 1, 1985, 135 (5) 3198-3204;
  • You have accessRestricted access
    The role of IL 1 in the antigen-specific activation of murine class II-restricted T lymphocyte clones.
    D J McKean, A Nilson, B N Beck, J Giri, S B Mizel and B S Handwerger
    J Immunol November 1, 1985, 135 (5) 3205-3216;
  • You have accessRestricted access
    IL 1-like activity in antigen-presenting human B cell lines.
    T L Gerrard and D J Volkman
    J Immunol November 1, 1985, 135 (5) 3217-3223;
  • You have accessRestricted access
    Release from mouse macrophages of acidic isoferritins that suppress hematopoietic progenitor cells is induced by purified L cell colony stimulating factor and suppressed by human lactoferrin.
    H E Broxmeyer, L Juliano, A Waheed and R K Shadduck
    J Immunol November 1, 1985, 135 (5) 3224-3231;
  • You have accessRestricted access
    Purification and partial characterization of a monoclonal "second order" suppressor factor specific for L-glutamic acid60-L-alanine30-L-tyrosine10.
    C W Turck, J A Kapp and D R Webb
    J Immunol November 1, 1985, 135 (5) 3232-3237;
  • You have accessRestricted access
    Purification and analysis of isoforms of soluble immune response suppressor (SIRS).
    D R Webb, K Mason, G Semenuk, T M Aune and C W Pierce
    J Immunol November 1, 1985, 135 (5) 3238-3242;
  • You have accessRestricted access
    Functional analysis of mononuclear cells infiltrating into tumors. II. Differential ability of mononuclear cells obtained from various tissues to produce helper factors that are involved in the generation of cytotoxic cells.
    T Uede, H Kohda, Y Ibayashi, H Osawa, T Diamantstein and K Kikuchi
    J Immunol November 1, 1985, 135 (5) 3243-3251;
  • You have accessRestricted access
    Establishment of rat-mouse T cell hybridomas that constitutively produce a soluble factor that is needed for the generation of cytotoxic cells: biochemical and functional characterization.
    T Uede, H Kohda, Y Ibayashi and K Kikuchi
    J Immunol November 1, 1985, 135 (5) 3252-3257;
  • You have accessRestricted access
    Priming and triggering of tumoricidal and schistosomulicidal macrophages by two sequential lymphokine signals: interferon-gamma and macrophage cytotoxicity inducing factor 2.
    P H Krammer, C F Kubelka, W Falk and A Ruppel
    J Immunol November 1, 1985, 135 (5) 3258-3263;
  • You have accessRestricted access
    Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).
    A D Procopio, P Allavena and J R Ortaldo
    J Immunol November 1, 1985, 135 (5) 3264-3271;
  • You have accessRestricted access
    Synergy between B cell differentiation factors and interleukin 2, using a monoclonal system.
    L Mayer, M K Crow and C Thompson
    J Immunol November 1, 1985, 135 (5) 3272-3276;
  • You have accessRestricted access
    Stimulation of human B lymphocytes by Nocardia-delipidated cell mitogen and derived fractions from N. opaca. Structure-activity relationship.
    R Barot-Ciorbaru, J Brochier, T Miyawaki, J L Preud'Homme, J F Petit, C Bona, N Taniguchi and J P Revillard
    J Immunol November 1, 1985, 135 (5) 3277-3283;
  • You have accessRestricted access
    Enhancement of the human antibody response by C8-substituted guanine ribonucleosides in synergy with interleukin 2.
    M G Goodman and W O Weigle
    J Immunol November 1, 1985, 135 (5) 3284-3288;
  • You have accessRestricted access
    Human peripheral blood monocytes release a 30,000 dalton factor (30 KD MF) that stimulates immunoglobulin production by activated B cells.
    R D Rossen, A H Laughter, F M Orson, F P Flagge, J L Cashaw and C V Sumaya
    J Immunol November 1, 1985, 135 (5) 3289-3297;
  • You have accessRestricted access
    Purification of human B cell growth factor.
    S R Mehta, D Conrad, R Sandler, J Morgan, R Montagna and A L Maizel
    J Immunol November 1, 1985, 135 (5) 3298-3302;
  • You have accessRestricted access
    Assembled topographic antigenic determinants of pigeon cytochrome c.
    C H Hannum and E Margoliash
    J Immunol November 1, 1985, 135 (5) 3303-3313;
  • You have accessRestricted access
    The B10.A mouse B cell response to pigeon cytochrome c is directed against the same area of the protein that is recognized by B10.A T cells in association with the Ek beta:Ek alpha Ia molecule.
    C H Hannum, L A Matis, R H Schwartz and E Margoliash
    J Immunol November 1, 1985, 135 (5) 3314-3322;
  • You have accessRestricted access
    Delineation of functional sites in HLA-B27 antigens. Molecular analysis of HLA-B27 variant Wewak I defined by cytolytic T lymphocytes.
    M A Vega, L Wallace, S Rojo, R Bragado, P Aparicio and J A López de Castro
    J Immunol November 1, 1985, 135 (5) 3323-3332;
  • You have accessRestricted access
    Biochemical characterization of the molecules reactive with Qa-6 antiserum and the monoclonal antibody 20-8-4: evidence for structural similarity with the Qa-2 molecule.
    S M Widacki, L Flaherty and R G Cook
    J Immunol November 1, 1985, 135 (5) 3333-3339;
  • You have accessRestricted access
    Guinea pig lymphocyte antigen molecules Ia.3,5 and Ia.8 share structural homology expected for alleles.
    L N Fuge Abruzzini, M P Zacheis and B D Schwartz
    J Immunol November 1, 1985, 135 (5) 3340-3347;
  • You have accessRestricted access
    Two distinct classes of IgG Fc receptors on a human monocyte line (U937) defined by differences in binding of murine IgG subclasses at low ionic strength.
    D H Jones, R J Looney and C L Anderson
    J Immunol November 1, 1985, 135 (5) 3348-3353;
  • You have accessRestricted access
    Antibodies to the alpha-subunit of insulin receptor from eggs of immunized hens.
    C S Song, J H Yu, D H Bai, P Y Hester and K H Kim
    J Immunol November 1, 1985, 135 (5) 3354-3359;
  • You have accessRestricted access
    Transepithelial transport of maternal antibody: purification of IgG receptor from newborn rat intestine.
    E R Jakoi, J Cambier and S Saslow
    J Immunol November 1, 1985, 135 (5) 3360-3364;
  • You have accessRestricted access
    Identification of recurrent idiotypes within the unrestricted anti-fluorescein immune response.
    D M Reinitz and E W Voss Jr
    J Immunol November 1, 1985, 135 (5) 3365-3371;
  • You have accessRestricted access
    Base specificity and idiotypy of anti-DNA autoantibodies reactive with synthetic nucleic acids.
    D W Ballard and E W Voss Jr
    J Immunol November 1, 1985, 135 (5) 3372-3380;
  • You have accessRestricted access
    Activation of the C3b receptor: effect of diacylglycerols and calcium mobilization.
    J J O'Shea, S A Siwik, T A Gaither and M M Frank
    J Immunol November 1, 1985, 135 (5) 3381-3387;
  • You have accessRestricted access
    Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
    J K Czop and K F Austen
    J Immunol November 1, 1985, 135 (5) 3388-3393;
  • You have accessRestricted access
    Effects of differentiation in vivo and of lymphokine treatment in vitro on the mobility of C3 receptors of human and mouse mononuclear phagocytes.
    F M Griffin Jr and P J Mullinax
    J Immunol November 1, 1985, 135 (5) 3394-3397;
  • You have accessRestricted access
    Expression of polypeptide segments of the human complement component C3 in E. coli: genetic and immunological characterization of cDNA clones specific for the alpha-chain of C3.
    D Ma, M J Sessler, T F Meyer, L Schrod, G M Hänsch and R Burger
    J Immunol November 1, 1985, 135 (5) 3398-3402;
  • You have accessRestricted access
    Exogenous ATP enhances calcium influx in intact thymocytes.
    J Lin, R Krishnaraj and R G Kemp
    J Immunol November 1, 1985, 135 (5) 3403-3410;
  • You have accessRestricted access
    Redistribution of protein kinase C activity in human monocytes: correlation with activation of the respiratory burst.
    M A Myers, L C McPhail and R Snyderman
    J Immunol November 1, 1985, 135 (5) 3411-3416;
  • You have accessRestricted access
    Relationship between membrane potential changes and superoxide-releasing capacity in resident and activated mouse peritoneal macrophages.
    S Kitagawa and R B Johnston Jr
    J Immunol November 1, 1985, 135 (5) 3417-3423;
  • You have accessRestricted access
    Induction of suppressor cells from peripheral blood T cells by 15-hydroperoxyeicosatetraenoic acid (15-HPETE).
    N Gualde, M Rigaud and J S Goodwin
    J Immunol November 1, 1985, 135 (5) 3424-3429;
  • You have accessRestricted access
    The stimulations of arachidonic acid metabolism by recombinant murine interleukin 1 and tumor promoters or 1-oleoyl-2-acetyl-glycerol are synergistic.
    L Levine and D M Xiao
    J Immunol November 1, 1985, 135 (5) 3430-3433;
  • You have accessRestricted access
    Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity: effects on intracellular cAMP and target cell binding.
    U Ramstedt, J Ng, H Wigzell, C N Serhan and B Samuelsson
    J Immunol November 1, 1985, 135 (5) 3434-3438;
  • You have accessRestricted access
    Phorbol myristate acetate receptors in human polymorphonuclear neutrophils.
    J Nishihira and J T O'Flaherty
    J Immunol November 1, 1985, 135 (5) 3439-3447;
  • You have accessRestricted access
    Phorbol ester induces tyrosine phosphorylation in normal and abnormal human B lymphocytes.
    A E Nel, M Navailles, D F Rosberger, G E Landreth, P J Goldschmidt-Clermont, G J Baldwin and R M Galbraith
    J Immunol November 1, 1985, 135 (5) 3448-3453;
  • You have accessRestricted access
    Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro.
    F Levi-Schaffer, K F Austen, J P Caulfield, A Hein, W F Bloes and R L Stevens
    J Immunol November 1, 1985, 135 (5) 3454-3462;
  • You have accessRestricted access
    Selective regulation of chemotactic lymphokine production. I. Selective potentiation of eosinophil chemotactic lymphokine production in alum hydroxy gel- and Bordetella pertussis vaccine-treated guinea pigs.
    K Sakata, K Tashiro, M Hirashima and H Hayashi
    J Immunol November 1, 1985, 135 (5) 3463-3467;
  • You have accessRestricted access
    Induction of germ-line anti-alpha 1-3 dextran antibody responses in mice by members of the Enterobacteriaceae family.
    J F Kearney, M T McCarthy, R Stohrer, W H Benjamin Jr and D E Briles
    J Immunol November 1, 1985, 135 (5) 3468-3472;
  • You have accessRestricted access
    Relationship between immune system and gram-negative bacteria. IV. T lymphocytes from Lpsd mice possess binding site(s) for Rb Salmonella.
    E Jirillo, S Antonaci, H Kiyono, S M Michalek and J R McGhee
    J Immunol November 1, 1985, 135 (5) 3473-3478;
  • You have accessRestricted access
    Effect of aging on antimicrobial immunity: old mice display a normal capacity for generating protective T cells and immunologic memory in response to infection with Listeria monocytogenes.
    M Løvik and R J North
    J Immunol November 1, 1985, 135 (5) 3479-3486;
  • You have accessRestricted access
    Immunoregulation in disseminated murine histoplasmosis: disturbances in the production of interleukins 1 and 2.
    S R Watson, S K Schmitt, D E Hendricks and W E Bullock
    J Immunol November 1, 1985, 135 (5) 3487-3493;
  • You have accessRestricted access
    Monoclonal antibody OKM5 inhibits the in vitro binding of Plasmodium falciparum-infected erythrocytes to monocytes, endothelial, and C32 melanoma cells.
    J W Barnwell, C F Ockenhouse and D M Knowles 2nd
    J Immunol November 1, 1985, 135 (5) 3494-3497;
  • You have accessRestricted access
    Production of IL 2 and IFN-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro.
    M Troye-Blomberg, G Andersson, M Stoczkowska, R Shabo, P Romero, M E Patarroyo, H Wigzell and P Perlmann
    J Immunol November 1, 1985, 135 (5) 3498-3504;
  • You have accessRestricted access
    Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines.
    C A Nacy, A H Fortier, M S Meltzer, N A Buchmeier and R D Schreiber
    J Immunol November 1, 1985, 135 (5) 3505-3511;
  • You have accessRestricted access
    H-2-restricted cytolysis of L cells doubly transformed with a cloned H-2Kb gene and cloned retroviral DNA.
    J P Abastado, F Plata, D Morello, F Daniel-Vedele and P Kourilsky
    J Immunol November 1, 1985, 135 (5) 3512-3519;
  • You have accessRestricted access
    Stable expression of cytolytic activity by influenza virus-specific cytotoxic T lymphocytes.
    M E Andrew, V L Braciale, T J Henkel, J A Hatch and T J Braciale
    J Immunol November 1, 1985, 135 (5) 3520-3523;
  • You have accessRestricted access
    Influenza viruses as lymphocyte mitogens. II. Role of I-E molecules in B cell mitogenesis by influenza A viruses of the H2 and H6 subtypes.
    A A Scalzo and E M Anders
    J Immunol November 1, 1985, 135 (5) 3524-3529;
  • You have accessRestricted access
    Cross-reactive recognition of mouse cells expressing the bm3 and bm11 mutations within H-2Kb by H-2Kb-restricted herpes simplex virus-specific cytotoxic T lymphocytes.
    S R Jennings
    J Immunol November 1, 1985, 135 (5) 3530-3536;
  • You have accessRestricted access
    Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    J F Bukowski and R M Welsh
    J Immunol November 1, 1985, 135 (5) 3537-3541;
  • You have accessRestricted access
    Complex regulation of class II gene expression: analysis with class II mutant cell lines.
    L H Glimcher, D J McKean, E Choi and J G Seidman
    J Immunol November 1, 1985, 135 (5) 3542-3550;
  • You have accessRestricted access
    Implications of the invariant gamma-chain on the intracellular transport of class II histocompatibility antigens.
    L Claesson-Welsh and P A Peterson
    J Immunol November 1, 1985, 135 (5) 3551-3557;
  • You have accessRestricted access
    Immunologic memory to phosphocholine. VII. Lack of T15 V1 gene utilization in Xid anti-PC hybridomas.
    M Brown, M Stenzel-Poore and M B Rittenberg
    J Immunol November 1, 1985, 135 (5) 3558-3563;
  • You have accessRestricted access
    A human-mouse chimeric immunoglobulin gene with a human variable region is expressed in mouse myeloma cells.
    L K Tan, V T Oi and S L Morrison
    J Immunol November 1, 1985, 135 (5) 3564-3567;
  • You have accessRestricted access
    Antigen presentation by Hodgkin's disease cells.
    R I Fisher, J Cossman, V Diehl and D J Volkman
    J Immunol November 1, 1985, 135 (5) 3568-3571;
  • You have accessRestricted access
    Characterization of the molecules on SJL/J lymphomas which stimulate syngeneic T cells.
    P H Brown and G J Thorbecke
    J Immunol November 1, 1985, 135 (5) 3572-3580;
  • You have accessRestricted access
    Characterization of SJL T cell clones responsive to syngeneic lymphoma (RCS): RCS-specific clones are stimulated by activated B cells.
    R H DeKruyff, P H Brown, G J Thorbecke and N M Ponzio
    J Immunol November 1, 1985, 135 (5) 3581-3586;
  • You have accessRestricted access
    An innate host response to the neoplastic cell: syngeneic rat tumor cells can elicit a rapid de novo lymphoid procoagulant response.
    P A Lando and T S Edgington
    J Immunol November 1, 1985, 135 (5) 3587-3595;
  • You have accessRestricted access
    Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
    M Giovarelli, A Santoni and G Forni
    J Immunol November 1, 1985, 135 (5) 3596-3603;
  • You have accessRestricted access
    Monoclonal antibodies for carcinoembryonic antigen (CEA) as a model system: identification of two novel CEA-related antigens in meconium and colorectal carcinoma tissue by Western blots and differential immunoaffinity chromatography.
    M Neumaier, U Fenger and C Wagener
    J Immunol November 1, 1985, 135 (5) 3604-3609;
  • You have accessRestricted access
    Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas.
    H Sekine, T Ohno and D W Kufe
    J Immunol November 1, 1985, 135 (5) 3610-3615;
  • You have accessRestricted access
    Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
    S Ramakrishnan, F M Uckun and L L Houston
    J Immunol November 1, 1985, 135 (5) 3616-3622;
  • You have accessRestricted access
    Recombinant interleukin 2 stimulates in vivo proliferation of adoptively transferred lymphokine-activated killer (LAK) cells.
    S E Ettinghausen, E H Lipford 3rd, J J Mulé and S A Rosenberg
    J Immunol November 1, 1985, 135 (5) 3623-3635;

LETTERS TO THE EDITOR

  • You have accessRestricted access
    Antiserum to PS myeloma protein overmeasures IgE.
    G A Molinaro, W C Eby, J Munson and D P Eskinazi
    J Immunol November 1, 1985, 135 (5) 3636-3637;
  • You have accessRestricted access
    Effects of certain peptides upon protein kinase and phosphorylation patterns of Molt 4b lymphoblasts.
    L Elias
    J Immunol November 1, 1985, 135 (5) 3637-3638;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 135, Issue 5
1 Nov 1985
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • COMMUNICATIONS
  • ARTICLES
  • LETTERS TO THE EDITOR
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606